MB-1 Vaccine

Indications

• Hypertension
• Angina pectoris
• Myocardial infarction
• Heart failure
• Arrhythmias
• Migraine prophylaxis

Dosage

Children: For children, the dosage is usually based on body weight and should be determined by a healthcare professional, refer to the BNF for Children for specific dosing guidelines.

Adults: The usual adult dose for hypertension is 50 mg once daily, which may be increased to 100 mg once daily if necessary.

Mechanism of action

Atenolol inhibits beta-1 adrenergic receptors located primarily in the heart. By blocking these receptors, atenolol decreases heart rate and contractile force, which leads to a reduction in cardiac output and oxygen consumption. This action helps to lower blood pressure and reduce the workload on the heart.

Pharmacodynamics

The pharmacodynamic effects of atenolol result in decreased heart rate, reduced myocardial contractility, and decreased conduction through the AV node. These effects help in controlling blood pressure and managing angina symptoms. Atenolol may also exhibit a mild antiarrhythmic effect due to its ability to slow AV node conduction.

Pharmacokinetics

Atenolol is well absorbed from the gastrointestinal tract, with a bioavailability of approximately 50%. It has a volume of distribution of about 3-5 L/kg and is primarily eliminated by the kidneys, with a half-life of approximately 6-9 hours in healthy individuals. The drug is not significantly metabolized by the liver, making it suitable for use in patients with liver impairment. Renal function should be monitored, as dosage adjustment may be required in patients with renal impairment.

Contra-indications

• Severe immunocompromised states
• Known hypersensitivity to the vaccine components
• Pregnancy (specific attenuated vaccines)

Adverse effects

• Mild fever
• Injection site reactions (redness, swelling, pain)
• Transient rash
• Rarely, more serious reactions such as Guillain-Barré Syndrome or anaphylaxis

Interactions

• Immunosuppressive drugs may reduce vaccine efficacy
• Concurrent administration with other live vaccines may require specific timing

Precautions

• History of allergy to vaccine components
• Consideration in patients with chronic diseases
• Monitoring for adverse effects post-vaccination

Pregnancy

Live attenuated vaccines are generally contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Most live attenuated vaccines are considered safe during breastfeeding, but consult local guidelines for specific recommendations.

Storage

Store in a refrigerator at 2-8 degrees Celsius, do not freeze.

Formulations

• Injectable suspension for subcutaneous or intramuscular administration
• Oral formulations for specific vaccines (e.g., oral polio vaccine)

Dosage

Children: Refer to specific product guidelines for paediatric dosing information, as it is dependent on the drug type and the clinical condition being treated.

Adults: Refer to specific product guidelines for dosing information, as doses vary widely based on the specific intermediate drug and indication.

Mechanism of action

The mechanism of action for intermediate drugs can vary widely depending on the specific agent. Generally, these drugs may interact with various receptors, enzymes, or cellular pathways to produce their therapeutic effects. For instance, some may modulate neurotransmitter systems, while others might inhibit specific metabolic pathways or enhance physiological processes.

Pharmacodynamics

Pharmacodynamics of intermediate drugs typically involves the relationship between drug concentration and its therapeutic effect. This can include the drug's efficacy, potency, and the duration of action, which are influenced by the drug's interactions with target sites in the body. The effects may also be dose-dependent, leading to varied responses in different populations or disease states.

Pharmacokinetics

Pharmacokinetics of intermediate drugs includes absorption, distribution, metabolism, and excretion (ADME). These processes determine how the drug is taken up into the body, how it is distributed to tissues, how it is metabolized (often in the liver), and how it is eliminated through urine or feces. Variability in pharmacokinetics can occur due to factors such as age, weight, organ function, and concurrent medications.

Pregnancy

The safety of intermediate drugs during pregnancy depends on the specific agent and its pharmacological properties. Consultation with a healthcare provider is recommended.

Breast-feeding

Safety during breastfeeding varies by drug; consult a healthcare provider for specific recommendations.

Storage

Intermediate drugs should be stored in a cool, dry place, away from direct sunlight and moisture.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Dosage

Children: Refer to specific active ingredient guidelines for appropriate paediatric dosing.

Adults: Refer to specific active ingredient guidelines for appropriate adult dosing.

Mechanism of action

Lyophilisates themselves do not have a direct mechanism of action, as they are not active substances but rather a means of preserving and delivering active pharmaceutical ingredients. The mechanism of action of the active ingredient contained within the lyophilisate will dictate its pharmacological effects.

Pharmacodynamics

The pharmacodynamics of a lyophilisate depends on the active pharmaceutical ingredient that has been lyophilized. For example, if the lyophilisate contains a vaccine, its pharmacodynamics would involve the stimulation of the immune system to produce an immune response against specific pathogens. In the case of hormonal lyophilisates, they may exert effects on target tissues and organs by binding to specific receptors and initiating cellular responses.

Pharmacokinetics

The pharmacokinetics of a drug in lyophilised form is influenced by how it is reconstituted and administered. Upon reconstitution, the drug is typically administered via injection or oral routes, depending on the formulation. The absorption, distribution, metabolism, and excretion (ADME) of the drug will vary according to its chemical nature and the route of administration. For many biologics, the half-life may be extended due to the formulation's stability, but specific pharmacokinetic parameters will depend on the active ingredient.

Pregnancy

Consult a healthcare professional before use. The safety of lyophilisate during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use. The safety of lyophilisate during breastfeeding has not been established.

Storage

Store in a cool, dry place. Protect from light and moisture. Follow specific storage instructions on the product label.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.